Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CPHC vs CRESW: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CPHC Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 10–0 Matrix Metrics)

CPHC Overall Winner 6-Pillar Tally: CPHC 5 – 0 CRESW (1 Tie) Matrix Metrics: CPHC 10 – 0 CRESW

As of Nov 20, 2026, Canterbury Park Holding Corporation 'New' (CPHC) is the stronger overall head-to-head candidate over Cresud S.A.C.I.F. y A. Warrant (CRESW) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CPHC carries a Unified Composite Score of 55.6/100 (HOLD) at $15.60 (20.1x Forward P/E, 5.5% operating margin), whereas CRESW carries 43.5/100 (HOLD) at $0.03 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: CPHC is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.4); meanwhile CRESW is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 19.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CPHC vs CRESW
CPHC NASDAQ Head-to-Head Winner
Canterbury Park Holding Corporation 'New' Common Stock
Services-Racing, Including Track Operation
$15.60
-0.83% 1D
Market Cap $81.8M
TTM Revenue $61M
Forward P/E 20.1x
Beta / 30D Vol 0.03β · 18% Vol
Unified Composite Score
55.6 / 100 HOLD
Tech 49.0 Fund 54.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope 0.0%) with fading momentum, RSI 46
RSI-14: 46.4 · SMA20: $15.70 · SMA50: $15.75
CRESW NASDAQ
Cresud S.A.C.I.F. y A. Warrant
Institutional Equity
$0.03
+1953.33% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 23.08β · 7022% Vol
Unified Composite Score
43.5 / 100 HOLD
Tech 40.0 Fund 48.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -12.4%), weak momentum, RSI 20
RSI-14: 19.7 · SMA20: $0.70 · SMA50: $1.03

6-Pillar Scorecard Institutional Category Breakdown (CPHC 5 – 0 CRESW)

Columns: Metric · CPHC · CRESW
1. Valuation Multiples CPHC
Forward P/E 20.1x N/M
Trailing P/E 131.1x N/M
PEG Ratio N/M N/M
EV / Revenue 1.3x N/M
2. Growth & Scale CPHC
Revenue Growth (YoY) +4.2% N/A
Earnings Growth (YoY) +87.9% N/A
TTM Revenue (USD) $61M N/A
Market Cap $81.8M N/A
3. Profitability & Quality CPHC
Gross Margin 33.5% N/A
Operating Margin 5.5% N/A
Net Profit Margin 1.0% N/A
Return on Equity (ROE) 0.7% N/A
4. Balance Sheet & Cash Flow CPHC
Cash Generation (TTM) $7.5M EBITDA N/A
Cash Flow Margin 12.3% EBITDA Mgn N/A
Net Cash / Leverage $16.36 Book/Sh · 0.7% ROE N/A ROE
Dividend Yield 1.79% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markdown
6. R&D & Supply-Chain Moat CPHC
OpEx & R&D Intensity 28.0% of Rev ($17M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Resorts & Casinos Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CPHC (10) vs CRESW (0)
Institutional Metric CPHC CRESW Criterion Row Edge
Market Capitalization
Scale
$81.8M N/A Larger Scale CPHC
Trailing P/E Ratio
Valuation
131.1x N/M Lower Multiple CPHC
Forward P/E Ratio
Valuation
20.1x N/M Lower Multiple CPHC
Revenue Growth (YoY)
Growth
+4.2% N/A Higher Growth CPHC
Operating Margin (TTM)
Profitability
5.5% N/A Higher Margin CPHC
Net Profit Margin
Profitability
1.0% N/A Higher Margin CPHC
Return on Equity (ROE)
Capital Efficiency
0.7% N/A Higher ROE CPHC
52-Week Range Position
Momentum
40% ($15–$17) 2% ($0–$2) Stronger Trend CPHC
Beta / 30D Volatility
Risk Regime
0.03β · 18% Vol 23.08β · 7022% Vol Lower Realized Risk CPHC
Unified Institutional Score
Composite Signal
55.6 / 100 (HOLD) 43.5 / 100 (HOLD) Higher Composite CPHC
Trailing 12M Revenue (USD)
Operating Scale
$61M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
33.5% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.3x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$7.5M EBITDA ($16.36 Book/Sh · 0.7% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CPHC +96.77 pp
CPHC: -0.82% · CRESW: -97.59%
3M Horizon CPHC +95.31 pp
CPHC: -1.38% · CRESW: -96.69%
6M Horizon CPHC +90.92 pp
CPHC: -4.8% · CRESW: -95.72%
1Y Horizon CPHC +90.92 pp
CPHC: -4.8% · CRESW: -95.72%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CPHC vs CRESW. Trailing 12-month operating profitability (CPHC 5.5% vs CRESW N/A) and valuation multiples (CPHC 20.1x vs CRESW N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CPHC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$61M
Gross Margin33.5%
Op. Margin5.5%
ROE / Fwd P/E0.7% · 20.1x
CRESW ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CPHC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CPHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CRESW UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CRESW Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CPHC Moat Profile Cyclical / Execution-Driven Positioning
Resorts & Casinos Operator
Competes within the Resorts & Casinos value chain with $81.8M market capitalization and 5.5% operating margin.
OpEx & R&D Reinvestment 28.0% of Rev ($17M)
90D Engineering Disclosures 0 Published
CRESW Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CPHC vs CRESW Key Questions & Quantitative Answers

As of Nov 20, 2026, Canterbury Park Holding Corporation 'New' (CPHC) is the stronger overall head-to-head candidate over Cresud S.A.C.I.F. y A. Warrant (CRESW) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CPHC carries a Unified Composite Score of 55.6/100 (HOLD) at $15.60 (20.1x Forward P/E, 5.5% operating margin), whereas CRESW carries 43.5/100 (HOLD) at $0.03 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: CPHC is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.4); meanwhile CRESW is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 19.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CPHC leads the Growth & Scale pillar: CPHC posts +4.2% YoY revenue growth and +87.9% YoY earnings growth on $61M TTM revenue (33.5% gross margin, 5.5% operating margin), compared with CRESW at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, CPHC generates $61M in USD-normalized revenue versus N/A for CRESW. In operating R&D and SG&A reinvestment, CPHC deploys 28.0% of Rev ($17M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CRESW.

CPHC screens cheaper on headline valuation multiples. CPHC trades at 20.1x Forward P/E, 131.1x Trailing P/E, N/M PEG, and 1.3x EV/Revenue (12.3% EBITDA margin), whereas CRESW trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CPHC (0.7% ROE) versus CRESW (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, CPHC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.03β · 18% Vol realized risk). By comparison, CRESW carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (23.08β · 7022% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.